MORGAN STANLEY PLC/CALL/MERCK & CO./180/0.1/17.01.25 Share Price

Warrant

DE000MB85N14

Real-time Bid/Ask 06:42:48 17/05/2024 pm IST
0.045 EUR / 0.069 EUR +14.00% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./180/0.1/17.01.25
Current month-23.08%
1 month-26.47%
Date Price Change
17/24/17 0.043 -14.00%
16/24/16 0.05 -9.09%
15/24/15 0.055 +7.84%
14/24/14 0.051 0.00%
13/24/13 0.051 -8.93%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 05:08 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB85N1
ISINDE000MB85N14
Date issued 30/06/2023
Strike 180 $
Maturity 17/01/2025 (245 Days)
Parity 10 : 1
Emission price 0.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.105
Lowest since issue 0.012
Spread 0.032
Spread %42.67%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.9 USD
Average target price
141.6 USD
Spread / Average Target
+8.22%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW